Protolabs experts discuss how software-driven workflows, additive manufacturing and built-in compliance are supporting ...

We all know that losing weight is difficult - and keeping it off is even harder. And now one leading scientist has a ...

Erectile dysfunction treatment has long relied on self-reporting and a narrow set of treatment options. Advances support an ...

First off, it’s worth looking at the original RAACM, a modular, low-cost cruise missile that leverages 3D printing to bring ...

Heart failure risk prediction improves when gut-derived biomarkers are added to traditional models, revealing residual risk ...

Fastening, joining and assembly specialists demonstrate why controlling heat—not force—makes the difference between a ...

Researchers have published research that demonstrated the processing of copper-coated diamond via PBF-LB Additive ...

Greystone Capital reports a +1.4% net return for Q1 2026, outperforming the S&P 500. Read the full analysis for more details ...

CT's air quality had improved over 50 years of increasingly rigorous federal regulations and enforcement. That progress is ...

Grab's growth is driven by robust EBITDA growth, a strong balance sheet, and underappreciated catalysts. Click here to read ...

Analysts dissect the streaming giant's first quarter earnings and parse why there was no guidance hike.

If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.